Neurocysticercosis, presentation of a case
DOI:
https://doi.org/10.59471/ijhsc2025286Keywords:
Cysticercosis, Neurocysticercosis, Taenia solium, TreatmentAbstract
Introduction: neurocysticercosis is a central nervous system infection caused by the larva of Taenia solium, which can lead to significant neurological symptoms such as headaches and seizures. This clinical case describes a 30-year-old male agricultural worker presenting symptoms consistent with this disease.
Patient Information: the 30-year-old patient presents with recurrent episodes of intense headaches and seizures, specifically involuntary movements in his left leg, accompanied by confusion and disorientation. His medical history is healthy, but he has consumed undercooked pork, which may have facilitated disease transmission. A computed tomography (CT) scan reveals multiple cysts in the brain, and serology for antibodies against T. solium is positive, confirming the diagnosis of neurocysticercosis.
Conclusions: the treatment of neurocysticercosis should be individualized, combining antiparasitics like albendazole and corticosteroids to manage inflammation. Education on prevention, especially regarding pork consumption, is crucial to reduce the incidence of this disease.
References
Garcia HH, Gonzalez AE, Gilman RH, for the Cysticercosis Working Group in Peru. Taenia solium Cysticercosis and Its Impact in Neurological Disease. Clin Microbiol Rev [Internet]. 27 de mayo de 2020 [citado 31 de marzo de 2025];33(3):10.1128/cmr.00085-19. Disponible en: https://journals.asm.org/doi/10.1128/cmr.00085-19
Gürbüz E, Aydemi R S, Barlik F, Saygin M, Yildiz R, Alkan S, et al. Bibliometric analysis of neurocysticercosis case reports and evaluation of presented cases. Microb Pathog [Internet]. marzo de 2025 [citado 31 de marzo de 2025];200:107315. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39848300/
Buque H, Vaz D, Lorenzo E, Tané S, Sidat M, Nzwalo H. Severe neurocysticercosis in a quaternary hospital from Mozambique: Case series analysis. Clin Neurol Neurosurg [Internet]. octubre de 2023 [citado 31 de marzo de 2025];233:107913. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37544023/
Coyle CM, Bustos JA, Garcia HH. Current challenges in neurocysticercosis: recent data and where we are heading. Curr Opin Infect Dis [Internet]. 1 de octubre de 2024 [citado 31 de marzo de 2025];37(5):313-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39088697/
Stelzle D, Makasi C, Schmidt V, Trevisan C, Van Damme I, Ruether C, et al. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. Infection [Internet]. 1 de agosto de 2023 [citado 31 de marzo de 2025];51(4):1127-39. Disponible en: https://doi.org/10.1007/s15010-023-02021-y
Monk EJ, Abba K, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev [Internet]. 2021 [citado 31 de marzo de 2025];(6). Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000215.pub5/full
Prodjinotho UF, Lema J, Lacorcia M, Schmidt V, Vejzagic N, Sikasunge C, et al. Host immune responses during Taenia solium Neurocysticercosis infection and treatment. PLoS Negl Trop Dis [Internet]. 16 de abril de 2020 [citado 31 de marzo de 2025];14(4):e0008005. Disponible en: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008005
Jin H, Kim W, Kim SH. A Neurocysticercosis Case from Timor-Leste, A Previously Unidentified Region of Human Taeniasis Endemicity. Am J Trop Med Hyg [Internet]. 14 de enero de 2025 [citado 31 de marzo de 2025];1(aop). Disponible en: https://www.ajtmh.org/view/journals/tpmd/aop/article-10.4269-ajtmh.24-0205/article-10.4269-ajtmh.24-0205.xml
Ta R, Blond BN. The prevalence of and contributors to neurocysticercosis in endemic regions. J Neurol Sci [Internet]. 15 de octubre de 2022 [citado 31 de marzo de 2025];441. Disponible en: https://www.jns-journal.com/article/S0022-510X(22)00255-6/abstract
Herrick JA, Bustos JA, Clapham P, Garcia HH, Loeb JA. Unique Characteristics of Epilepsy Development in Neurocysticercosis. Am J Trop Med Hyg [Internet]. 18 de mayo de 2020 [citado 31 de marzo de 2025];103(2):639-45. Disponible en: https://www.ajtmh.org/view/journals/tpmd/103/2/article-p639.xml
Carpio A, Romo ML, Hauser WA, Kelvin EA. New understanding about the relationship among neurocysticercosis, seizures, and epilepsy. Seizure - Eur J Epilepsy [Internet]. 1 de agosto de 2021 [citado 31 de marzo de 2025];90:123-9. Disponible en: https://www.seizure-journal.com/article/S1059-1311(21)00053-4/fulltext
Brutto OHD, Garcia HH. The many facets of disseminated parenchymal brain cysticercosis: A differential diagnosis with important therapeutic implications. PLoS Negl Trop Dis [Internet]. 18 de noviembre de 2021 [citado 31 de marzo de 2025];15(11):e0009883. Disponible en: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009883
White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis [Internet]. 3 de abril de 2018 [citado 31 de marzo de 2025];66(8):e49-75. Disponible en: https://doi.org/10.1093/cid/cix1084.
Published
Issue
Section
License
Copyright (c) 2025 Maikro Osvaldo Chávez Moya , Leodanis Hernández Cabrera , Orlando Jesús Espinoza Romero , Neisy Pérez Ramos (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
How to Cite
